CPRX · Catalyst Pharmaceuticals, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-15 | Andrews William T. |
Chief Medical Officer |
Other↓
Filing footnotes — Common Stock, par value $0.001 per share (Direct)
The reported securities were disposed of in connection with the consummation of the acquisition of the Issuer by Angelini Pharma S.p.A. (the "Merger") |
Common Stock, par value $0.001 per share
|
2,309 |
| 2026-07-15 | MCENANY PATRICK J |
Director |
Other↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Restricted Stock Units
|
3,552 |
| 2026-07-15 | Sundaram Preethi |
Chief Strategy Officer |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
106,873 |
| 2026-07-15 | Daly Richard J |
Director, President and CEO |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option was fully vested. |
Options to purchase common stock
|
20,000 |
| 2026-07-15 | Daly Richard J |
Director, President and CEO |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
491,160 |
| 2026-07-15 | Andrews William T. |
Chief Medical Officer |
Other↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Restricted Stock Units
|
12,209 |
| 2026-07-15 | Tierney David S |
Director |
Other↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Restricted Stock Units
|
1,414 |
| 2026-07-15 | Miller Steve |
Chief Op. & Scientific Officer |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option was fully vested. |
Options to purchase common stock
|
275,000 |
| 2026-07-15 | Andrews William T. |
Chief Medical Officer |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
124,447 |
| 2026-07-15 | Miller Steve |
Chief Op. & Scientific Officer |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option was fully vested. |
Options to purchase common stock
|
180,000 |
| 2026-07-15 | Harper Molly |
Director |
Other↓
Filing footnotes — Common Stock, par value $0.001 per share (Direct)
The reported securities were disposed of in connection with the consummation of the acquisition of the Issuer by Angelini Pharma S.p.A. (the "Merger") |
Common Stock, par value $0.001 per share
|
3,694 |
| 2026-07-15 | Thompson Tamar |
Director |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option was fully vested. |
Options to purchase common stock
|
40,000 |
| 2026-07-15 | Thompson Tamar |
Director |
Other↓
Filing footnotes — Common Stock, par value $0.001 per share (Direct)
The reported securities were disposed of in connection with the consummation of the acquisition of the Issuer by Angelini Pharma S.p.A. (the "Merger") |
Common Stock, par value $0.001 per share
|
3,773 |
| 2026-07-15 | Curran Daniel J. |
Director |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
18,115 |
| 2026-07-15 | Harper Molly |
Director |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
29,524 |
| 2026-07-15 | DENKHAUS DONALD A |
Director |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option was fully vested. |
Options to purchase common stock
|
15,000 |
| 2026-07-15 | Daly Richard J |
Director, President and CEO |
Other↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Restricted Stock Units
|
40,013 |
| 2026-07-15 | Miller Steve |
Chief Op. & Scientific Officer |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
158,454 |
| 2026-07-15 | Kalb Michael Wayne |
Executive Vice President & CFO |
Other↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Restricted Stock Units
|
13,788 |
| 2026-07-15 | Miller Steve |
Chief Op. & Scientific Officer |
Other↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Restricted Stock Units
|
47,826 |
| 2026-07-15 | Harper Molly |
Director |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
18,115 |
| 2026-07-15 | Del Carmen Jeffrey |
Chief Commercial Officer |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
106,873 |
| 2026-07-15 | Elsbernd Brian |
Chief Compliance/Legal Officer |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option was fully vested. |
Options to purchase common stock
|
132,000 |
| 2026-07-15 | Thompson Tamar |
Director |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
29,524 |
| 2026-07-15 | Elsbernd Brian |
Chief Compliance/Legal Officer |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
147,621 |
| 2026-07-15 | MCENANY PATRICK J |
Director |
Other↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Restricted Stock Units
|
10,540 |
| 2026-07-15 | Kalb Michael Wayne |
Executive Vice President & CFO |
Other↓
Filing footnotes — Common Stock, par value $0.001 per share (Direct)
The reported securities were disposed of in connection with the consummation of the acquisition of the Issuer by Angelini Pharma S.p.A. (the "Merger") |
Common Stock, par value $0.001 per share
|
13,665 |
| 2026-07-15 | Daly Richard J |
Director, President and CEO |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option was fully vested. |
Options to purchase common stock
|
30,000 |
| 2026-07-15 | Harper Molly |
Director |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option was fully vested. |
Options to purchase common stock
|
12,500 |
| 2026-07-15 | Thompson Tamar |
Director |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
23,248 |
| 2026-07-15 | Curran Daniel J. |
Director |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
40,000 |
| 2026-07-15 | Tierney David S |
Director |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
18,115 |
| 2026-07-15 | Harper Molly |
Director |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option was fully vested. |
Options to purchase common stock
|
15,000 |
| 2026-07-15 | Miller Steve |
Chief Op. & Scientific Officer |
Other↓
Filing footnotes — Common Stock, par value $0.001 per share (Direct)
The reported securities were disposed of in connection with the consummation of the acquisition of the Issuer by Angelini Pharma S.p.A. (the "Merger") |
Common Stock, par value $0.001 per share
|
1,093,803 |
| 2026-07-15 | DENKHAUS DONALD A |
Director |
Other↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Restricted Stock Units
|
5,468 |
| 2026-07-15 | MCENANY PATRICK J |
Director |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
43,591 |
| 2026-07-15 | Elsbernd Brian |
Chief Compliance/Legal Officer |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option was fully vested. |
Options to purchase common stock
|
135,000 |
| 2026-07-15 | Tierney David S |
Director |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
29,524 |
| 2026-07-15 | Kalb Michael Wayne |
Executive Vice President & CFO |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
169,248 |
| 2026-07-15 | Tierney David S |
Director |
Other↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Restricted Stock Units
|
5,468 |
| 2026-07-15 | Russo Gregg |
Chief HR Officer |
Other↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Restricted Stock Units
|
6,197 |
| 2026-07-15 | MCENANY PATRICK J |
Director |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
34,921 |
| 2026-07-15 | Del Carmen Jeffrey |
Chief Commercial Officer |
Other↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Restricted Stock Units
|
32,257 |
| 2026-07-15 | Russo Gregg |
Chief HR Officer |
Other↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Restricted Stock Units
|
2,752 |
| 2026-07-15 | Thompson Tamar |
Director |
Other↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Restricted Stock Units
|
1,894 |
| 2026-07-15 | MCENANY PATRICK J |
Director |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option was fully vested. |
Options to purchase common stock
|
740,000 |
| 2026-07-15 | Del Carmen Jeffrey |
Chief Commercial Officer |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Options to purchase common stock
|
167,918 |
| 2026-07-15 | Del Carmen Jeffrey |
Chief Commercial Officer |
Other↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU. Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Restricted Stock Units
|
8,039 |
| 2026-07-15 | Del Carmen Jeffrey |
Chief Commercial Officer |
Other↓
Filing footnotes — Common Stock, par value $0.001 per share (Direct)
The reported securities were disposed of in connection with the consummation of the acquisition of the Issuer by Angelini Pharma S.p.A. (the "Merger") |
Common Stock, par value $0.001 per share
|
14,337 |
| 2026-07-15 | Miller Steve |
Chief Op. & Scientific Officer |
Other↓
Filing footnotes — Options to purchase common stock (Direct)
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. Each Option was fully vested. |
Options to purchase common stock
|
185,000 |